Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Syngene International Ltd. ( (IN:SYNGENE) ) has issued an announcement.
Syngene International Limited announced the release of an investor presentation shared with investors and analysts during a meeting on March 12, 2025. The presentation did not include any new information beyond what is already publicly available, and it is accessible on the company’s website. This announcement reinforces Syngene’s commitment to transparency and maintaining open communication with its stakeholders, potentially strengthening its position in the market.
More about Syngene International Ltd.
Syngene International Limited operates in the biotechnology industry, providing integrated research, development, and manufacturing services. The company focuses on delivering solutions across the pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors.
YTD Price Performance: -22.36%
Average Trading Volume: 42,260
Current Market Cap: 274.5B INR
Learn more about SYNGENE stock on TipRanks’ Stock Analysis page.